Demand cancer drugs that truly help patients

Comment

Ajay Aggarwal. Nature. 2018 Apr.

. 2018 Apr;556(7700):151.

doi: 10.1038/d41586-018-04154-9.

No abstract available

Keywords: Medical research; Policy.

Comment on

Early palliative care for patients with metastatic non-small-cell lung cancer.
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Temel JS, et al. N Engl J Med. 2010 Aug 19;363(8):733-42. doi: 10.1056/NEJMoa1000678. N Engl J Med. 2010. PMID: 20818875 Clinical Trial.
Cancer Drugs Approved on the Basis of a Surrogate End Point and Subsequent Overall Survival: An Analysis of 5 Years of US Food and Drug Administration Approvals.
Kim C, Prasad V. Kim C, et al. JAMA Intern Med. 2015 Dec;175(12):1992-4. doi: 10.1001/jamainternmed.2015.5868. JAMA Intern Med. 2015. PMID: 26502403 No abstract available.
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13.
Davis C, Naci H, Gurpinar E, Poplavska E, Pinto A, Aggarwal A. Davis C, et al. BMJ. 2017 Oct 4;359:j4530. doi: 10.1136/bmj.j4530. BMJ. 2017. PMID: 28978555 Free PMC article.